Suscribirse

Mechanisms underlying differential food allergy response to heated egg - 11/08/11

Doi : 10.1016/j.jaci.2011.01.057 
Gustavo Martos, BS a, b, Ivan Lopez-Exposito, PhD a, b, Ramon Bencharitiwong, BS a, M. Cecilia Berin, PhD a, Anna Nowak-Węgrzyn, MD a,
a Department of Pediatrics and Jaffe Food Allergy Institute, Mount Sinai School of Medicine, New York, NY 
b Institute of Food Science Research (CIAL, CSIC-UAM), Madrid, Spain 

Reprint requests: Anna Nowak-Węgrzyn, MD, Mount Sinai School of Medicine, Department of Pediatrics, Box 1198, One Gustave L. Levy Place, New York, NY 10029.

Abstract

Background

Egg white proteins are usually subjected to heating, making them edible for the majority of children with egg allergy.

Objective

We sought to investigate the underlying mechanisms responsible for the reduced allergenicity displayed by heat-treated egg white allergens.

Methods

C3H/HeJ mice were orally sensitized with ovalbumin (OVA) or ovomucoid and challenged with native or heated proteins to evaluate their allergenicity. Immunoreactivity was assessed by immunoblotting using sera from children with egg allergy. In vitro gastrointestinal digestion of native and heated OVA and ovomucoid was studied by SDS-PAGE and liquid chromatography. Intestinal uptake of intact native and heated OVA and ovomucoid by human intestinal epithelial (Caco-2) cells was investigated. Rat basophil leukemia cells passively sensitized with mouse serum and human basophils passively sensitized with serum from children with egg allergy were used to assess the effector cell activation by heated, digested, and transported OVA and ovomucoid.

Results

Heated OVA and ovomucoid did not induce symptoms of anaphylaxis in sensitized mice when administered orally. Heating did not completely destroy IgE-binding capacity of OVA or ovomucoid but enhanced in vitro digestibility of OVA. Digestion of both OVA and ovomucoid diminished mediator release in rat basophil leukemia assay and basophil activation. Heating of allergens prevented transport across human intestinal epithelial cells in a form capable of triggering basophil activation or T-cell activation.

Conclusion

Heat treatment reduces allergenicity of OVA and ovomucoid. This is partially a result of the enhanced gastrointestinal digestibility of heated OVA and the inability of heated OVA or ovomucoid to be absorbed in a form capable of triggering basophils.

El texto completo de este artículo está disponible en PDF.

Key words : Egg allergy, ovalbumin, ovomucoid, heat treatment, heating, gastrointestinal digestion, antigen absorption, mice oral sensitization, anaphylaxis, basophil activation, passive sensitization

Abbreviations used : Bis-Tris, DIG, kUA/L, MLN, NHR, OVA, PP, RBL


Esquema


 G.M. was supported by the Spanish Research Council through the JAE program and by the Ministry of Science and Innovation through project AGL2008-01740. R.B. was supported in part by the Nutricia Foundation. C.B. was supported by National Institutes of Health (NIH)–NIAID AI044236. A.N.-W. was supported in part by NIH-NIAID AI059318. The project was supported in part by grant no. CTSA ULI RR 029887 from the National Center for Research Resources, a component of the NIH. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of National Center for Research Resources or the NIH.
 Disclosure of potential conflict of interest: G. Martos receives research support from the Spanish Research Council. A. Nowak-Węgrzyn receives research support from the National Institutes of Health–NIAID. The rest of the authors have declared that they have no conflict of interest.


© 2011  American Academy of Allergy, Asthma & Immunology. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 127 - N° 4

P. 990 - avril 2011 Regresar al número
Artículo precedente Artículo precedente
  • Ingested allergens must be absorbed systemically to induce systemic anaphylaxis
  • Richard T. Strait, Ashley Mahler, Simon Hogan, Marat Khodoun, Akira Shibuya, Fred D. Finkelman
| Artículo siguiente Artículo siguiente
  • A peptide derived from the Wiskott-Aldrich syndrome (WAS) protein-interacting protein (WIP) restores WAS protein level and actin cytoskeleton reorganization in lymphocytes from patients with WAS mutations that disrupt WIP binding
  • Michel J. Massaad, Narayanaswamy Ramesh, Severine Le Bras, Silvia Giliani, Lucia D. Notarangelo, Waleed Al-Herz, Luigi D. Notarangelo, Raif S. Geha

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.